These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Identification of Novel Tau Interactions with Endoplasmic Reticulum Proteins in Alzheimer's Disease Brain. Meier S; Bell M; Lyons DN; Ingram A; Chen J; Gensel JC; Zhu H; Nelson PT; Abisambra JF J Alzheimers Dis; 2015; 48(3):687-702. PubMed ID: 26402096 [TBL] [Abstract][Full Text] [Related]
4. Differential induction and spread of tau pathology in young PS19 tau transgenic mice following intracerebral injections of pathological tau from Alzheimer's disease or corticobasal degeneration brains. Boluda S; Iba M; Zhang B; Raible KM; Lee VM; Trojanowski JQ Acta Neuropathol; 2015 Feb; 129(2):221-37. PubMed ID: 25534024 [TBL] [Abstract][Full Text] [Related]
5. The use of mouse models to study cell-to-cell transmission of pathological tau. Narasimhan S; Lee VMY Methods Cell Biol; 2017; 141():287-305. PubMed ID: 28882308 [TBL] [Abstract][Full Text] [Related]
6. Unique pathological tau conformers from Alzheimer's brains transmit tau pathology in nontransgenic mice. Guo JL; Narasimhan S; Changolkar L; He Z; Stieber A; Zhang B; Gathagan RJ; Iba M; McBride JD; Trojanowski JQ; Lee VM J Exp Med; 2016 Nov; 213(12):2635-2654. PubMed ID: 27810929 [TBL] [Abstract][Full Text] [Related]
7. GFP-Mutant Human Tau Transgenic Mice Develop Tauopathy Following CNS Injections of Alzheimer's Brain-Derived Pathological Tau or Synthetic Mutant Human Tau Fibrils. Gibbons GS; Banks RA; Kim B; Xu H; Changolkar L; Leight SN; Riddle DM; Li C; Gathagan RJ; Brown HJ; Zhang B; Trojanowski JQ; Lee VM J Neurosci; 2017 Nov; 37(47):11485-11494. PubMed ID: 28986461 [TBL] [Abstract][Full Text] [Related]
8. Involvement of endoplasmic reticulum stress in tauopathy. Sakagami Y; Kudo T; Tanimukai H; Kanayama D; Omi T; Horiguchi K; Okochi M; Imaizumi K; Takeda M Biochem Biophys Res Commun; 2013 Jan; 430(2):500-4. PubMed ID: 23237806 [TBL] [Abstract][Full Text] [Related]
9. Pathological Tau Strains from Human Brains Recapitulate the Diversity of Tauopathies in Nontransgenic Mouse Brain. Narasimhan S; Guo JL; Changolkar L; Stieber A; McBride JD; Silva LV; He Z; Zhang B; Gathagan RJ; Trojanowski JQ; Lee VMY J Neurosci; 2017 Nov; 37(47):11406-11423. PubMed ID: 29054878 [TBL] [Abstract][Full Text] [Related]
10. MIR-NATs repress MAPT translation and aid proteostasis in neurodegeneration. Simone R; Javad F; Emmett W; Wilkins OG; Almeida FL; Barahona-Torres N; Zareba-Paslawska J; Ehteramyan M; Zuccotti P; Modelska A; Siva K; Virdi GS; Mitchell JS; Harley J; Kay VA; Hondhamuni G; Trabzuni D; Ryten M; Wray S; Preza E; Kia DA; Pittman A; Ferrari R; Manzoni C; Lees A; Hardy JA; Denti MA; Quattrone A; Patani R; Svenningsson P; Warner TT; Plagnol V; Ule J; de Silva R Nature; 2021 Jun; 594(7861):117-123. PubMed ID: 34012113 [TBL] [Abstract][Full Text] [Related]
11. Synaptic Localisation of Tau. Hanger DP; Goniotaki D; Noble W Adv Exp Med Biol; 2019; 1184():105-112. PubMed ID: 32096032 [TBL] [Abstract][Full Text] [Related]
12. Tau Interacting Proteins: Gaining Insight into the Roles of Tau in Health and Disease. Stancu IC; Ferraiolo M; Terwel D; Dewachter I Adv Exp Med Biol; 2019; 1184():145-166. PubMed ID: 32096036 [TBL] [Abstract][Full Text] [Related]
13. Tauopathies and tau oligomers. Takashima A J Alzheimers Dis; 2013; 37(3):565-8. PubMed ID: 23948895 [TBL] [Abstract][Full Text] [Related]
14. Tau Secretion. Ruan Z; Ikezu T Adv Exp Med Biol; 2019; 1184():123-134. PubMed ID: 32096034 [TBL] [Abstract][Full Text] [Related]
15. Acetylated tau in Alzheimer's disease: An instigator of synaptic dysfunction underlying memory loss: Increased levels of acetylated tau blocks the postsynaptic signaling required for plasticity and promotes memory deficits associated with tauopathy. Tracy TE; Gan L Bioessays; 2017 Apr; 39(4):. PubMed ID: 28083916 [TBL] [Abstract][Full Text] [Related]
16. Tauopathies: The Role of Tau in Cellular Crosstalk and Synaptic Dysfunctions. Caamaño-Moreno M; Gargini R Neuroscience; 2023 May; 518():38-53. PubMed ID: 35272005 [TBL] [Abstract][Full Text] [Related]
17. Tau pathology in Alzheimer disease and other tauopathies. Iqbal K; Alonso Adel C; Chen S; Chohan MO; El-Akkad E; Gong CX; Khatoon S; Li B; Liu F; Rahman A; Tanimukai H; Grundke-Iqbal I Biochim Biophys Acta; 2005 Jan; 1739(2-3):198-210. PubMed ID: 15615638 [TBL] [Abstract][Full Text] [Related]
18. Tau and Axonal Transport Misregulation in Tauopathies. Combs B; Mueller RL; Morfini G; Brady ST; Kanaan NM Adv Exp Med Biol; 2019; 1184():81-95. PubMed ID: 32096030 [TBL] [Abstract][Full Text] [Related]
19. [Brain insulin signaling and Tau: impact for Alzheimer's disease and Tauopathies]. Joly-Amado A; Gratuze M; Benderradji H; Vieau D; Buée L; Blum D Med Sci (Paris); 2018 Nov; 34(11):929-935. PubMed ID: 30526837 [TBL] [Abstract][Full Text] [Related]
20. Tau Ser208 phosphorylation promotes aggregation and reveals neuropathologic diversity in Alzheimer's disease and other tauopathies. Xia Y; Prokop S; Gorion KM; Kim JD; Sorrentino ZA; Bell BM; Manaois AN; Chakrabarty P; Davies P; Giasson BI Acta Neuropathol Commun; 2020 Jun; 8(1):88. PubMed ID: 32571418 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]